Effectiveness of [67Cu]Cu-trastuzumab as a theranostic against HER2-positive breast cancer
Jessica Pougoue Ketchemen, Fabrice Ngoh Njotu, Hanan Babeker, Stephen Ahenkorah, Anjong Florence Tikum, Emmanuel Nwangele, Nikita Henning, Frederik Cleeren, Humphrey Fonge
Topics & Concepts
TrastuzumabInternalizationFlow cytometryMonoclonal antibodyImmunoconjugateChemistryIn vitroMedicineBreast cancerPharmacologyCancer researchCancerAntibodyReceptorInternal medicineImmunologyBiochemistryHER2/EGFR in Cancer ResearchRadiopharmaceutical Chemistry and ApplicationsMonoclonal and Polyclonal Antibodies Research